Insulin resistance in drug naive patients with multiple sclerosis

Background/Aim. Due to the fact that there is a relatively small number of data related to systemic insulin abnormalities in the multiple sclerosis (MS), the main objective of our study was to determine whether a dysbalance of glucose and insulin metabolism exist in patients with natural co...

Full description

Saved in:
Bibliographic Details
Main Authors: Kostić Smiljana, Kolić Ivana, Raičević Ranko, Stojanović Zvezdana, Kostić Dejan, Dinčić Evica
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2017-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600082K.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849697592697421824
author Kostić Smiljana
Kolić Ivana
Raičević Ranko
Stojanović Zvezdana
Kostić Dejan
Dinčić Evica
author_facet Kostić Smiljana
Kolić Ivana
Raičević Ranko
Stojanović Zvezdana
Kostić Dejan
Dinčić Evica
author_sort Kostić Smiljana
collection DOAJ
description Background/Aim. Due to the fact that there is a relatively small number of data related to systemic insulin abnormalities in the multiple sclerosis (MS), the main objective of our study was to determine whether a dysbalance of glucose and insulin metabolism exist in patients with natural course of MS. Our hypothesis was that the metabolic disorder that characterizes state of the insulin resistance (IR) and reduced insulin sensitivity (IS) in untreated patients with MS could play a role in disease progression and degree of functional disability. Methods. The study included 31 patients with relapsing-remitting (RR) MS and 14 healthy controls from the same geographic area matched by age, ethnicity and number of smokers. The glucose tolerance, IS, and IR were examined using an oral glucose tolerance test (OGTT) and using basal plasma glucose and insulin levels. The functional disability and disease progression were evaluated by the Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Severity Score (MSSS). Results. The MS patients tolerated glucose equally well as the healthy controls. Basal concentrations of insulin were significantly higher in the MS group (p < 0.05), as well as insulin plasma level 30 min after oral glucose load (p < 0.01). The patients with MS had significantly higher values of homeostasis model assessment indexes of IR (HOMA-IR) (p = 0.027; p = 0.028). The percentage of IS (HOMA2 %S) and whole body IS index (ISI Matsuda) showed significantly lower values in the MS patients than in the controls (p = 0.005; p = 0.001). The insulinogenic index in the first 30 min of OGTT was significantly higher in MS patients (p = 0.005). The measures of functional disability and MS progression did not correlate significantly with the investigated parameters of IR and IS indexes. Conclusion. This study demonstrates for the first time the existence of hyperinsulinemia, reduced insulin sensitivity and normal glucose tolerance that indicate the initial phase of IR in the natural course of MS. Additional research is necessary in order to define the mechanisms of occurrence and the impact of IR on the complex pathophysiological processes in MS.
format Article
id doaj-art-761fc0207a1a49e79896f3beab7baec5
institution DOAJ
issn 0042-8450
2406-0720
language English
publishDate 2017-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-761fc0207a1a49e79896f3beab7baec52025-08-20T03:19:11ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502406-07202017-01-0174656357010.2298/VSP160218082K0042-84501600082KInsulin resistance in drug naive patients with multiple sclerosisKostić Smiljana0Kolić Ivana1Raičević Ranko2Stojanović Zvezdana3Kostić Dejan4Dinčić Evica5Military Medical Academy, Clinic of Neurology, BelgradeInstitute of Nuclear Sciences „Vinča“, Laboratory for Radiobiology and Molecular Genetics, BelgradeMilitary Medical Academy, Clinic of Neurology, Belgrade + University of Defence, Faculty of Medicine of the Military Medical Academy, BelgradeUniversity of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade + Institute of Nuclear Sciences „Vinča“, Laboratory for Radiobiology and Molecular Genetics, BelgradeMilitary Medical Academy, Institute of Radiology, BelgradeMilitary Medical Academy, Clinic of Neurology, Belgrade + University of Defence, Faculty of Medicine of the Military Medical Academy, BelgradeBackground/Aim. Due to the fact that there is a relatively small number of data related to systemic insulin abnormalities in the multiple sclerosis (MS), the main objective of our study was to determine whether a dysbalance of glucose and insulin metabolism exist in patients with natural course of MS. Our hypothesis was that the metabolic disorder that characterizes state of the insulin resistance (IR) and reduced insulin sensitivity (IS) in untreated patients with MS could play a role in disease progression and degree of functional disability. Methods. The study included 31 patients with relapsing-remitting (RR) MS and 14 healthy controls from the same geographic area matched by age, ethnicity and number of smokers. The glucose tolerance, IS, and IR were examined using an oral glucose tolerance test (OGTT) and using basal plasma glucose and insulin levels. The functional disability and disease progression were evaluated by the Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Severity Score (MSSS). Results. The MS patients tolerated glucose equally well as the healthy controls. Basal concentrations of insulin were significantly higher in the MS group (p < 0.05), as well as insulin plasma level 30 min after oral glucose load (p < 0.01). The patients with MS had significantly higher values of homeostasis model assessment indexes of IR (HOMA-IR) (p = 0.027; p = 0.028). The percentage of IS (HOMA2 %S) and whole body IS index (ISI Matsuda) showed significantly lower values in the MS patients than in the controls (p = 0.005; p = 0.001). The insulinogenic index in the first 30 min of OGTT was significantly higher in MS patients (p = 0.005). The measures of functional disability and MS progression did not correlate significantly with the investigated parameters of IR and IS indexes. Conclusion. This study demonstrates for the first time the existence of hyperinsulinemia, reduced insulin sensitivity and normal glucose tolerance that indicate the initial phase of IR in the natural course of MS. Additional research is necessary in order to define the mechanisms of occurrence and the impact of IR on the complex pathophysiological processes in MS.http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600082K.pdfmultiple sclerosisinsulin resistanceglucose tolerance testquestionnaires
spellingShingle Kostić Smiljana
Kolić Ivana
Raičević Ranko
Stojanović Zvezdana
Kostić Dejan
Dinčić Evica
Insulin resistance in drug naive patients with multiple sclerosis
Vojnosanitetski Pregled
multiple sclerosis
insulin resistance
glucose tolerance test
questionnaires
title Insulin resistance in drug naive patients with multiple sclerosis
title_full Insulin resistance in drug naive patients with multiple sclerosis
title_fullStr Insulin resistance in drug naive patients with multiple sclerosis
title_full_unstemmed Insulin resistance in drug naive patients with multiple sclerosis
title_short Insulin resistance in drug naive patients with multiple sclerosis
title_sort insulin resistance in drug naive patients with multiple sclerosis
topic multiple sclerosis
insulin resistance
glucose tolerance test
questionnaires
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2017/0042-84501600082K.pdf
work_keys_str_mv AT kosticsmiljana insulinresistanceindrugnaivepatientswithmultiplesclerosis
AT kolicivana insulinresistanceindrugnaivepatientswithmultiplesclerosis
AT raicevicranko insulinresistanceindrugnaivepatientswithmultiplesclerosis
AT stojanoviczvezdana insulinresistanceindrugnaivepatientswithmultiplesclerosis
AT kosticdejan insulinresistanceindrugnaivepatientswithmultiplesclerosis
AT dincicevica insulinresistanceindrugnaivepatientswithmultiplesclerosis